Sweetch is an Artificial Intelligence based platform for large scale prediction, prevention and outcome improvement of chronic diseases - diabetes, hypertension, hyperlipidemia, and obesity. They believe that every individual should live a healthier lifestyle. Currently, no scalable and cost-effective solution exists that helps the prediabetic population, therefore providing some sort of guidance is vital. Sweetch reduces the risk of diabetes and improves outcomes of chronic diseases by implementing a personalized intervention that focuses on emotional support and motivation to drive behavior change.
Sweetch is a game-changing platform that predicts personal diabetes risk and drives long-term behavioral change to prevent diabetes in a way never seen before. Sweetch was developed as a platform for any large-scale clinical outcome prediction, and personalized, data-driven, wellness prevention intervention in the most cost-effective patients. Diabetes is our first use case.
Total Funding: $15,532,000
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2C, B2B
Company Size: 1 to 25
Founded: 2013
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Sweetch
